INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,484,055 | +489.6% | 456,623 | +2006.4% | 0.01% | +200.0% |
| Q3 2019 | $1,439,000 | +92.4% | 21,678 | +266.5% | 0.00% | +200.0% |
| Q3 2018 | $748,000 | +53.9% | 5,915 | -28.9% | 0.00% | 0.0% |
| Q4 2017 | $486,000 | +1.5% | 8,315 | +0.7% | 0.00% | 0.0% |
| Q3 2017 | $479,000 | +48.8% | 8,259 | +518.2% | 0.00% | 0.0% |
| Q2 2015 | $322,000 | -38.3% | 1,336 | -27.9% | 0.00% | 0.0% |
| Q1 2015 | $522,000 | – | 1,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |